Olshan Client CorMedix Announces $12 Million IPO

Firm News

Olshan’s client CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of cardiorenal disease, announced the completion of its $12 million IPO. Yehuda Markovits and Kenneth S. Mantel, with assistance from Kenneth A. Schlesinger and Michael D. DeDonato, represented CorMedix.

Media Contact

Marketing Contact
Mizi Mehaj
Marketing & Administrative Manager

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.